Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

Onego Bio

Onego Bio is a food ingredient company producing egg protein through fermentation
2022
51-100
Helsinki, Southern Finland, Finland

Investment Funding

Total Funding Amount

$72.6M

Last Funding Amount

$1.1M

Last Funding Date

23-10-2024

Startup Stage

Grant

Lead Investors

Business Finland, EIC Accelerator, NordicNinja VC, U.S. Department of Defense

Revenue

$1M to $10M

People

Founders

About

Onego Bio is a food ingredient company on a mission to create a more resilient food system through its product Bioalbumen®—the first non-animal egg protein with an amino acid sequence identical to the natural protein. Made through precision fermentation, Bioalbumen® matches the nutrition and functionality of traditional eggs while delivering greater supply stability, consistent pricing, and 90% lower environmental impact. With a proven industrial-scale process, FDA GRAS status, and technological development that advances positive unit economics, Onego Bio is addressing the $300BN egg market by helping food manufacturers meet rising demand for reliable protein without compromising on performance. From baked goods to sauces and ready-to-eat meals, Bioalbumen® fits seamlessly into existing formulations—making the transition to smarter proteins easier than ever.

Something missing or incorrect on this page? Help us enrich this information